Thrombosis Matters – Netherlands

What?

A series of Dutch newsletters in print and online on the subject of deep vein thrombosis and pulmonary embolism in oncology patients. In conjunction, there is also a website www.thrombosismatters.nl, which will be launched in the near future.

Clients

Bayer Nederland BV en Bayer Netherlands BV

Indication

Thrombosis

Target audience

Cardiologists, hematologists and vascular specialists in the Netherlands

Goal

Providing education regarding the usage of rivaroxaban in the treatment of cancer-related thrombosis and pulmonary embolism, based on the most recent data from clinical trials, congresses and international publications.

Result

This project has only just started in 2020, the number of subsribers is rising steadily.